m-PEG7-4-nitrophenyl carbonate
CAS No. 678150-56-6
m-PEG7-4-nitrophenyl carbonate ( —— )
Catalog No. M24690 CAS No. 678150-56-6
m-PEG7-4-nitrophenyl carbonate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
2MG | 83 | In Stock |
|
5MG | 125 | In Stock |
|
10MG | 185 | In Stock |
|
25MG | 277 | In Stock |
|
50MG | 422 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product Namem-PEG7-4-nitrophenyl carbonate
-
NoteResearch use only, not for human use.
-
Brief Descriptionm-PEG7-4-nitrophenyl carbonate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Descriptionm-PEG7-4-nitrophenyl carbonate is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.
-
Synonyms——
-
PathwayPROTACs
-
TargetPROTAC
-
RecptorPEGs;Alkyl/ether
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number678150-56-6
-
Formula Weight461.5
-
Molecular FormulaC20H31NO11
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESCOCCOCCOCCOCCOCCOCCOC(OC1=CC=C([N+]([O-])=O)C=C1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
molnova catalog
related products
-
CM11
A homo-PROTAC, bivalent small-molecule dimerizer of the VHL E3 ubiquitin ligase to induce self-degradation; induces potent, rapid and proteasome-dependent self-degradation of VHL in different cell lines.
-
BTK PROTAC 10
BTK PROTAC 10 is a novel potent PROTAC for BTK with DC50 of 1.1 nM in cultured Ramos cells.
-
ARV-771
ARV-771 is a potent BET degrader based on PROTAC technology with Kds of 34 nM, 4.7 nM, 8.3 nM, 7.6 nM, 9.6 nM, and 7.6 nM for BRD2(1), BRD2(2), BRD3(1), BRD3(2), BRD4(1), and BRD4(2), respectively.